Ensign Peak Advisors, Inc Bridge Bio Pharma, Inc. Transaction History

Ensign Peak Advisors, Inc

$55.3 Billion
Q4 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 1,975,249 shares of BBIO stock, worth $72.8 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,975,249

Previous 1,885,754 4.75%

Holding current value

$72.8 Million

Previous $48 Million 12.89%

% of portfolio

0.1%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$22.35 - $29.5 $2 Million - $2.64 Million	89,495 Added 4.75%	1,975,249 $54.2 Million
Q3 2024 Nov 14, 2024	BUY	$23.91 - $31.3 $5.73 Million - $7.5 Million	239,552 Added 14.55%	1,885,754 $48 Million
Q2 2024 Aug 13, 2024	BUY	$23.0 - $31.04 $11.7 Million - $15.7 Million	506,845 Added 44.49%	1,646,202 $41.7 Million
Q1 2024 May 14, 2024	BUY	$27.35 - $40.45 $10.8 Million - $15.9 Million	394,286 Added 52.92%	1,139,357 $35.2 Million
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $2.7 Million - $4.93 Million	112,361 Added 17.76%	745,071 $30.1 Million
Q3 2023 Nov 13, 2023	SELL	$16.89 - $35.01 $7.56 Million - $15.7 Million	-447,549 Reduced 41.43%	632,710 $16.7 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $1.84 Million - $4.75 Million	256,300 Added 31.11%	1,080,259 $17.9 Million
Q4 2022 Feb 13, 2023	BUY	$6.74 - $11.52 $1.77 Million - $3.02 Million	262,461 Added 46.74%	823,959 $6.28 Million
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $569,980 - $887,274	71,786 Added 14.66%	561,498 $5.58 Million
Q2 2022 Aug 12, 2022	BUY	$5.21 - $12.14 $128,317 - $298,996	24,629 Added 5.3%	489,712 $4.45 Million
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $52,745 - $123,311	-7,186 Reduced 1.52%	465,083 $4.72 Million
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $29,030 - $136,248	-2,551 Reduced 0.54%	472,269 $7.88 Million
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $4.25 Million - $5.83 Million	90,682 Added 23.61%	474,820 $22.3 Million
Q2 2021 Aug 13, 2021	BUY	$46.47 - $63.93 $1.34 Million - $1.84 Million	28,815 Added 8.11%	384,138 $23.4 Million
Q1 2021 May 12, 2021	BUY	$55.47 - $72.35 $9.74 Million - $12.7 Million	175,617 Added 97.72%	355,323 $21.9 Million
Q4 2020 Feb 12, 2021	SELL	$38.38 - $71.11 $1.03 Million - $1.92 Million	-26,945 Reduced 13.04%	179,706 $12.8 Million
Q3 2020 Nov 12, 2020	BUY	$27.2 - $42.19 $1.57 Million - $2.43 Million	57,568 Added 38.61%	206,651 $7.75 Million
Q2 2020 Aug 12, 2020	BUY	$22.22 - $35.69 $152,162 - $244,405	6,848 Added 4.81%	149,083 $4.86 Million
Q1 2020 May 11, 2020	BUY	$16.11 - $36.23 $512,459 - $1.15 Million	31,810 Added 28.81%	142,235 $4.13 Million
Q4 2019 Feb 14, 2020	BUY	$17.96 - $46.63 $1.98 Million - $5.15 Million	110,425 New	110,425 $3.87 Million

Others Institutions Holding BBIO

# of Institutions

321

Shares Held

176M

Call Options Held

13M

Put Options Held

2.48M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.46B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Bridge Bio Pharma, Inc. Transaction History